Description of 3 Cases in Vietnam of Aspirin Desensitization in Patients With Coronary Artery Disease and Coexisting Aspirin Hypersensitivity

Aspirin (ASA) hypersensitivity comprises types I to III (Cox-1 mediated) and types IV and V (IgE antibody mediated). Rapid, low-dose (81-325 mg/day) ASA desensitization regimens are known to be useful in establishing ASA tolerance in patients with coronary artery disease and coexisting ASA/nonsteroi...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Nguyen, Dinh, Chu Chi, Hieu, Van Nguyen, Doan, Craig, Timothy J, van Nunen, Sheryl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651182/
https://www.ncbi.nlm.nih.gov/pubmed/23282385
http://dx.doi.org/10.1097/WOX.0b013e3182718327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651182/
https://www.ncbi.nlm.nih.gov/pubmed/23282385
http://dx.doi.org/10.1097/WOX.0b013e3182718327

Ejemplares similares